Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00497653 · ClinicalTrials.gov registry record · Phase 2
Oral Administration of DCI to Women With PCOS
A Phase 2 study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT00497653 is a Phase 2 study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 13 participants.
The verdict
NCT00497653, a Phase 2 study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
To determine if oral DCI administration to women with PCOS increases the total DCI content in urine and blood, and, if so, if that change is accompanied by i) an increase in DCI-IPG release in blood (as determined by bioactivity) during an oral glucose challenge and ii) an increase in whole-body insulin sensitivity.
Interventions
- DRUG Placebo
- DRUG DCI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2001-02 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00497653
The ClinicalTrials.gov registry entry for NCT00497653 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00497653 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00497653 about?
NCT00497653 is a clinical study titled "Oral Administration of DCI to Women With PCOS". To determine if oral DCI administration to women with PCOS increases the total DCI content in urine and blood, and, if so, if that change is accompanied by i) an increase in DCI-IPG release in blood (as determined by bioactivity) during an oral glucose challenge and ii) an increase in whole-body ins...
What is the current status of trial NCT00497653?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2001-02. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00497653?
The interventions under investigation include: Placebo (DRUG), DCI (DRUG).
Who is sponsoring clinical trial NCT00497653?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.